about
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaTargeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Interleukin-2-inducible T-cell kinase (ITK) targeting by BMS-509744 does not affect cell viability in T-cell prolymphocytic leukemia (T-PLL).
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the design of ITK inhibitors.
@en
type
label
Advances in the design of ITK inhibitors.
@en
prefLabel
Advances in the design of ITK inhibitors.
@en
P2860
P1476
Advances in the design of ITK inhibitors.
@en
P2093
Jean-Damien Charrier
Ronald M A Knegtel
P2860
P304
P356
10.1517/17460441.2013.769520
P407
P577
2013-02-07T00:00:00Z